AZN vs NVO: stock comparison and AI forecast
Astrazeneca Plc (AZN) and Novo Nordisk A S (NVO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AZN Astrazeneca Plc
- Price
- $183.88 +1.5% · 6M
- Market Cap
- $285.01B
- P/E Ratio
- 13.3x
- Size
- mega-cap
- AI Forecast
NVO Novo Nordisk A S
- Price
- $40.00 -5.3% · 6M
- Market Cap
- $177.76B
- P/E Ratio
- 3.0x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AZN is 1.6 times larger than NVO by market capitalization ($285.01B against $177.76B).
- NVO trades at 3.0 times trailing earnings, AZN at 13.3 times.
- Over the last six months AZN returned +1.5% and NVO -5.3%.
- NVO turns 34.0% of its revenue into net income, against 15.4% for AZN.
- NVO carries 1.80 times debt per unit of equity, against 1.34 times for AZN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AZN | NVO |
|---|---|---|
| Market Cap | $285.01B | $177.76B |
| P/E Ratio | 13.28x | 2.97x |
| EPS | $13.85 | $13.48 |
| Revenue/Share | $90.46 | $34.48 |
| FCF/Share | $20.96 | $9.66 |
Profitability & Margins
| Metric | AZN | NVO |
|---|---|---|
| ROE | 44.5% | 176.6% |
| ROA | 19.0% | 63.1% |
| ROIC | 36.0% | 132.4% |
| Gross Margin | 81.8% | 83.4% |
| Operating Margin | 21.4% | 43.0% |
| Net Margin | 15.4% | 34.0% |
| EBT Margin | 19.0% | 42.8% |
| Tax Rate | 18.7% | 20.6% |
Financial Health
| Metric | AZN | NVO |
|---|---|---|
| Current Ratio | 0.94x | 0.80x |
| Quick Ratio | 0.72x | 0.57x |
| D/E Ratio | 1.34x | 1.80x |
| Financial Leverage | 2.34x | 2.80x |
| Working Capital | -$1.89B | -$6.79B |
Cash Flow
| Metric | AZN | NVO |
|---|---|---|
| Operating Cash Flow | $39.11B | $64.99B |
| Free Cash Flow | $32.48B | $42.93B |
| Capital Spending | -$6.62B | -$22.06B |
| OCF Growth YoY | 32.6% | 115.7% |
| FCF Growth YoY | 0.0% | 0.0% |
| FCF/Sales | 23.2% | 28.0% |
| CapEx/Sales | 4.7% | 14.4% |
Operational Efficiency
| Metric | AZN | NVO |
|---|---|---|
| Asset Turnover | 1.23x | 1.86x |
| Receivables Turnover | 9.2x | – |
| Inventory Turnover | 3.9x | 3.4x |
| Fixed Assets Turnover | 10.8x | – |
| Days Sales Outstanding | 40 days | – |
| Days Inventory | 94 days | 108 days |
| Payables Period | 362 days | – |
| Cash Conversion Cycle | -229 days | – |
Income Statement
| Metric | AZN | NVO |
|---|---|---|
| Total Revenue | $140.21B | $153.22B |
| Operating Income | $30.00B | $65.83B |
| Net Income | $21.64B | $52.04B |
| R&D Expense | $34.37B | $23.79B |
| SG&A Expense | $49.70B | – |
| Cost of Goods Sold | $25.50B | $25.45B |
Dividend & Shareholder Information
| Metric | AZN | NVO |
|---|---|---|
| Shares Outstanding | 1550M | 4444M |
| Net Income Growth | 89.5% | 104.6% |
| EPS Growth | 89.2% | 24.9% |
AZN vs NVO: stock comparison and AI forecast
Which is bigger, AZN or NVO?
AZN is 1.6 times larger than NVO by market capitalization ($285.01B against $177.76B).
Which is cheaper on earnings, AZN or NVO?
NVO trades at 3.0 times trailing earnings, AZN at 13.3 times.
Which stock performed better over the last six months, AZN or NVO?
Over the last six months AZN returned +1.5% and NVO -5.3%.
Which one does Intratio's AI model rank higher, AZN or NVO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.